Fig. 4.
Chromatogram of marketed formulation of OLM, AML and HCTZ.
Chromatogram of marketed formulation of olmesartan (OLM, Rf= 0.77), amlodipine (AML, Rf = 0.21) and hydrochlorthiazide (HCTZ, Rf = 0.47)
Chromatogram of marketed formulation of OLM, AML and HCTZ.
Chromatogram of marketed formulation of olmesartan (OLM, Rf= 0.77), amlodipine (AML, Rf = 0.21) and hydrochlorthiazide (HCTZ, Rf = 0.47)